Molecular Diagnosis and Treatment of Neurodegenerative Diseases

A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".

Deadline for manuscript submissions: closed (31 July 2023) | Viewed by 367

Special Issue Editors


E-Mail Website
Guest Editor
Molecular Biology and Genetics Department, Faculty of Science, Mugla Sitki Kocman University, 48000 Kotekli, Mentese, Mugla, Turkey
Interests: molecular pathways of neurodegeneration; neuroprotection; neurodegeneration; nervous system cancers

E-Mail Website
Guest Editor
Basic Medicine Department, Faculty of Medicine, Aydin Adnan Menderes University, 09010 Efeler, Aydin, Turkey
Interests: molecular neurobiology; neurodegeneration; brain tumors; excitotoxicity; neuroprotection

Special Issue Information

Dear Colleagues,

Neurodegeneration is the progressive loss of neuronal structure and function resulting in the death of neurons and has a very complex and multifactorial progression. Therefore, the term “neurodegenerative disease” corresponds to a variety of conditions that finally lead to neuronal disruption and death. Among the known mechanisms of neurodegenerative diseases are misfolding/accumulation of proteins, disruption of intracellular calcium balance, mitochondrial dysfunction, formation of oxidative stress and DNA damage. Since neurodegenerative diseases have multifactorial etiologies, there are numerous obstacles impeding their diagnosis and treatment, and causing them to be categorized as incurable diseases. One major obstacle is the poor characterization of disease pathophysiology. For instance, some of the diseases have a genetic basis, while others do not have any known genetic defects. In addition, there are pathogenic interactions between various intracellular processes and molecules contributing to disease progression, making it more sophisticated. It is incontrovertible that it is difficult to develop diagnostic and treatment methods for a disease group whose molecular basis is not well understood. However, despite all the difficulties, the search for biomarkers to develop more effective diagnostic approaches and, accordingly, the efforts to develop new treatment regimens continue actively.

Considering the multifaceted and challenging nature of neurodegenerative diseases, this Special Issue aims at discussing current molecular approaches used in the diagnosis and/or treatment of different neurodegenerative diseases, as well as emerging and promising new molecular diagnostic and treatment strategies with their advantages and disadvantages.

Dr. Ayşegül Yildiz
Dr. Gizem Donmez Yalcin
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • neurodegeneration
  • neuroinflammation
  • neurodegenerative diseases
  • molecular diagnosis
  • diagnostics
  • biomarkers for neurodegeneration
  • neuroprotection
  • preventive treatment
  • ALS
  • Alzheimer’s disease
  • Parkinson’s disease
  • Huntington disease
  • Lewy body dementia
  • Friedreich’s ataxia
  • molecular neurobiology
  • protein misfolding

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop